tiprankstipranks
RegenXBio (RGNX)
NASDAQ:RGNX
Holding RGNX?
Track your performance easily

RegenXBio (RGNX) Financial Statements

831 Followers

RegenXBio Financial Overview

RegenXBio's market cap is currently ―. The company's EPS TTM is $-5.034; its P/E ratio is -1.91; RegenXBio is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-1.13. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 24.20M$ 22.30M$ 15.62M$ 22.21M$ 28.91M
Gross Profit$ 11.81M$ 11.72M$ 11.34M$ 10.97M$ 16.53M
EBIT$ -59.60M$ -52.54M$ -61.43M$ -61.68M$ -60.24M
EBITDA$ -55.64M$ -48.02M$ -57.72M$ -57.34M$ -55.87M
Net Income Common Stockholders$ -59.60M$ -52.99M$ -63.33M$ -62.89M$ -61.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 255.46M$ 290.36M$ 338.70M$ 275.26M$ 301.89M
Total Assets$ 519.11M$ 569.38M$ 629.22M$ 573.97M$ 633.79M
Total Debt$ 84.06M$ 85.54M$ 87.25M$ 89.29M$ 90.70M
Net Debt$ -171.40M$ -204.82M$ -251.45M$ -185.97M$ -211.19M
Total Liabilities$ 217.70M$ 221.11M$ 238.55M$ 262.23M$ 270.69M
Stockholders Equity$ 301.42M$ 348.23M$ 390.67M$ 311.74M$ 363.10M
Cash Flow-
Free Cash Flow$ -40.88M$ -45.97M$ -56.01M$ -41.89M$ -50.85M
Operating Cash Flow$ -40.55M$ -45.50M$ -55.45M$ -40.76M$ -49.41M
Investing Cash Flow$ 50.26M$ -268.00K$ 13.18M$ 33.97M$ 38.66M
Financing Cash Flow$ -10.86M$ -9.45M$ 120.72M$ -11.96M$ -4.80M
Currency in USD

RegenXBio Earnings and Revenue History

RegenXBio Debt to Assets

RegenXBio Cash Flow

RegenXBio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis